Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol, Version 6, 08 Jul 2020, MHRA
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
G. Organisation Responsibilities
Appendix I - Expectations for Specific Serious Breach Topics
Appendix II Examples of Serious Breaches Notified to MHRA (this is not an exhaustive list)
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Kommende kliniske studier
-
NCT05880784RekrutteringKlinisk revisjon Pakke med essensielle ikke-smittsomme sykdommer (PEN) Peer Coaching Implementeringsstudie med blandet metode
-
NCT05880628Rekruttering
-
NCT05880641Har ikke rekruttert ennåPerifer arteriell sykdom Aorta sykdommer Aorto-iliaca aterosklerose
-
NCT05880758RekrutteringOvervekt Kardiometabolsk syndrom
-
NCT05880602Har ikke rekruttert ennåUrinveisinfeksjon
-
NCT05880680Har ikke rekruttert ennåAneurisme Aneurisme, revnet
-
NCT05880576Har ikke rekruttert ennåKoarktasjon av aorta Aortabueobstruksjon
-
NCT05880810Har ikke rekruttert ennå
-
NCT05880706Har ikke rekruttert ennå
-
NCT05880667Har ikke rekruttert ennåOndartet neoplasma i magen Neoplasma - Mykt vev bekken Malignt Sekundært
Clinical Research Jobs
-
Clinical Trial Associate - Client-dedicated - Belgium
-
Principal Reg Affairs Spec
-
Technicien Chromatographie - H/F - CDI
-
Animal Care Technician II
-
Director, Global Capital Planning & Contractor Safety
-
Apheresis Registered Nurse - Part Time
-
Animal care Assistant
-
Administratief Project Ondersteuner
-
Technicien animalier cycle VSDL - F/H - CDI
-
Assistant(e) soins aux animaux
-
Assistant Manager Biomanufacturing
-
Technicien Chromatographie Macromolécules - H/F - CDI